Market Place
Sourcing Support
Emergent BioSolutions Executes Contract Options For TEMBEXA
26 Sep 2024 //
GLOBENEWSWIRE
Emergent closes on buying smallpox drug Tembexa from Chimerix
28 Sep 2022 //
ENDPTS
Emergent acquires global rights for oral smallpox antiviral from Chimerix
27 Sep 2022 //
PHARMACEUTICAL-TECHNOLOGY
Chimerix Announces TEMBEXA Procurement Agreement for Approximately $25.3M
24 Jun 2022 //
GLOBENEWSWIRE
Emergent BioSolutions to Acquire from Chimerix, Exclusive WW Rights to TEMBEXA
16 May 2022 //
PRESS RELEASE
Emergent adds another arrow to its medical ountermeasures quiver
16 May 2022 //
FIERCEPHARMA
Chimerix Presents Data Brincidofovir as a Potential Treatment for Smallpox
29 Jan 2020 //
GLOBENEWSWIRE
Chimerix now can’t even recruit patients for their trials
09 May 2019 //
ENDPTS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.